Literature DB >> 9520302

Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood.

N Kruse1, M Pette, K Toyka, P Rieckmann.   

Abstract

In order to facilitate cytokine mRNA detection in blood cells, we have developed a highly reproducible and easily performed RNA isolation method for use with whole blood. Previously frozen human whole blood samples were lysed in guanidine thiocyanate solution to isolate total RNA. After reverse transcription a PCR method was applied to detect beta-actin and cytokine mRNA expression (interleukin-(IL)2, IL4, IL10, tumor necrosis factor alpha (TNF alpha) and interferon gamma (IFN gamma)). The presence of cDNA was confirmed by agarose gel electrophoresis and quantitated on-line using sequence-specific fluorochrome labeled internal oligonucleotide probes. This quantitative method is based on the cleavage of fluorescent dye labeled probes by the 5' --> 3' endonuclease activity of the Taq DNA polymerase during PCR and measurement of fluorescence intensity by a Sequence Detector System. The signal generated was directly proportional to the starting copy number of target molecules in the sample over 6 log concentrations and quantitative analysis of cDNA concentrations was performed in comparison to beta-actin or cytokine cDNA standards. mRNAs coding for beta-actin and TNF alpha were readily detectable in cDNAs prepared from the whole blood of eight healthy donors, while the other cytokines were expressed in lower amounts (IFN gamma, IL10) or were undetectable (IL2, IL4). The assay described is highly reproducible, requires no post PCR manipulation of the amplicons and permits the analysis of several hundred PCR reactions per day. Using this method it is possible to detect and quantify cytokine mRNA expression reliably in small amounts of previously frozen blood even after storage of samples for at least several months.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9520302     DOI: 10.1016/s0022-1759(97)00188-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  20 in total

1.  CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.

Authors:  T Jinquan; S Quan; H H Jacobi; H O Madsen; C Glue; P S Skov; H J Malling; L K Poulsen
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

2.  The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone.

Authors:  E Schmidt; S Reimer; N Kruse; E B Bröcker; D Zillikens
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.

Authors:  L K Chang; S T Liu
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

4.  Variations in cytokine mRNA expression during normal human pregnancy.

Authors:  N Kruse; M Greif; N F Moriabadi; L Marx; K V Toyka; P Rieckmann
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

5.  High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

Authors:  Katayoun Rezvani; Stephan Mielke; Mojgan Ahmadzadeh; Yasemin Kilical; Bipin N Savani; Josette Zeilah; Keyvan Keyvanfar; Aldemar Montero; Nancy Hensel; Roger Kurlander; A John Barrett
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

6.  Quantitative real-time polymerase chain reaction for the core facility using TaqMan and the Perkin-Elmer/Applied Biosystems Division 7700 Sequence Detector.

Authors:  D S Grove
Journal:  J Biomol Tech       Date:  1999-03

7.  NFAT4 deficiency results in incomplete liver regeneration following partial hepatectomy.

Authors:  Ketsia B Pierre; Christopher M Jones; Janene M Pierce; Ian B Nicoud; T Mark Earl; Ravi S Chari
Journal:  J Surg Res       Date:  2008-08-27       Impact factor: 2.192

8.  Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.

Authors:  Jennifer A Wargo; Paul F Robbins; Yong Li; Yangbing Zhao; Mona El-Gamil; Diana Caragacianu; Zhili Zheng; Julie A Hong; Stephanie Downey; David S Schrump; Steven A Rosenberg; Richard A Morgan
Journal:  Cancer Immunol Immunother       Date:  2008-08-02       Impact factor: 6.968

9.  Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis.

Authors:  A Bayas; M Stasiolek; N Kruse; K V Toyka; K Selmaj; R Gold
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

10.  Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

Authors:  Stephan Mielke; Katayoun Rezvani; Bipin N Savani; Raquel Nunes; Agnes S M Yong; John Schindler; Roger Kurlander; Victor Ghetie; Elizabeth J Read; Scott R Solomon; Ellen S Vitetta; A John Barrett
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.